Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blinded Study on Consecutive Transfusable Platelet Products Tested With the ThromboLUX® Platelet Quality Test

NCT02158416 is registered in ClinicalTrials.gov with LightIntegra Technology as lead sponsor.

NCT NCT02158416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02158416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blinded Study on Consecutive Transfusable Platelet Products Tested With the ThromboLUX® Platelet Quality Test
Lead sponsor
LightIntegra Technology
Phase
Observational
Overall status
Completed
Start date
December 31, 2013
Completion date
November 30, 2014
Enrollment
116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

poor platelet transfusion outcome